13
Nov 2026
Molecular Designs secures first FDA clearance for SimplicityDx Panel FluA/FluB/RSV assay
Molecular Designs, a physician-founded developer and manufacturer of molecular infectious disease assays, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance (K262789) for its SimplicityDx Panel FluA/FluB/RSV, the company's first FDA-cleared assay.







